According to Marketbeat's latest report, stock research analysts at Societe Generale have upgraded their rating on Philip Morris International (NYSE: PM) from "sell" to "hold" and issued a memo to investors on February 13th.
PMI released its 2023 financial report on February 8th. The report stated that iQOS will be test marketed in the United States this year. Prior to this, the company settled a global patent dispute with British American Tobacco (BAT).
Other research analysts have recently published reports on this stock as well. Redburn Atlantic released a research report on Philip Morris International stock on Thursday, November 16, giving it a "neutral" rating and a target price of $95.00. UBS Group, in a research report on January 23, downgraded their rating on Philip Morris International from "buy" to "sell" and reduced their target price from $105.00 to $86.50. Lastly, JPMorgan Chase Bank published a research report on November 29, raising their target price on Philip Morris International from $110.00 to $115.00 and giving the company an "overweight" rating.
One analyst has issued a sell rating, three analysts have issued a hold rating, and six analysts have issued a buy rating. According to data from MarketBeat.com, the consensus rating for Philip Morris International is "moderate buy" with an average target price of $107.39.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
